BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carey EJ, Iyer VN, Nelson DR, Nguyen JH, Krowka MJ. Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency-related cirrhosis: LT for AAT Deficiency-Related Cirrhosis. Liver Transpl 2013;19:1370-6. [DOI: 10.1002/lt.23744] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Cardoso FS, Karvellas CJ. Respiratory Complications Before and After Liver Transplant. J Intensive Care Med 2019;34:355-63. [PMID: 29886790 DOI: 10.1177/0885066618781526] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Zamora M. Surgery for patients with Alpha 1 Antitrypsin Deficiency: A review. The American Journal of Surgery 2019;218:639-47. [DOI: 10.1016/j.amjsurg.2018.10.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Hamesch K, Strnad P. Non-Invasive Assessment and Management of Liver Involvement in Adults With Alpha-1 Antitrypsin Deficiency. Chronic Obstr Pulm Dis 2020;7:260-71. [PMID: 32697896 DOI: 10.15326/jcopdf.7.3.2019.0161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Udompap P, Kim D, Kim WR. Current and Future Burden of Chronic Nonmalignant Liver Disease. Clin Gastroenterol Hepatol. 2015;13:2031-2041. [PMID: 26291665 DOI: 10.1016/j.cgh.2015.08.015] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 11.5] [Reference Citation Analysis]
5 McElvaney GN, Sandhaus RA, Miravitlles M, Turino GM, Seersholm N, Wencker M, Stockley RA. Clinical considerations in individuals with α1-antitrypsin PI*SZ genotype. Eur Respir J 2020;55:1902410. [PMID: 32165400 DOI: 10.1183/13993003.02410-2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
6 Guillaud O, Jacquemin E, Couchonnal E, Vanlemmens C, Francoz C, Chouik Y, Conti F, Duvoux C, Hilleret MN, Kamar N, Houssel-Debry P, Neau-Cransac M, Pageaux GP, Gonzales E, Ackermann O, Gugenheim J, Lachaux A, Ruiz M, Radenne S, Debray D, Lacaille F, McLin V, Duclos-Vallée JC, Samuel D, Coilly A, Dumortier J. Long term results of liver transplantation for alpha-1 antitrypsin deficiency. Dig Liver Dis 2021;53:606-11. [PMID: 33139195 DOI: 10.1016/j.dld.2020.10.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Torres-Durán M, Lopez-Campos JL, Barrecheguren M, Miravitlles M, Martinez-Delgado B, Castillo S, Escribano A, Baloira A, Navarro-Garcia MM, Pellicer D, Bañuls L, Magallón M, Casas F, Dasí F. Alpha-1 antitrypsin deficiency: outstanding questions and future directions. Orphanet J Rare Dis 2018;13:114. [PMID: 29996870 DOI: 10.1186/s13023-018-0856-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 23] [Article Influence: 15.7] [Reference Citation Analysis]
8 Townsend SA, Edgar RG, Ellis PR, Kantas D, Newsome PN, Turner AM. Systematic review: the natural history of alpha-1 antitrypsin deficiency, and associated liver disease. Aliment Pharmacol Ther. 2018;47:877-885. [PMID: 29446109 DOI: 10.1111/apt.14537] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 12.3] [Reference Citation Analysis]
9 de Serres F, Blanco I. Role of alpha-1 antitrypsin in human health and disease. J Intern Med 2014;276:311-35. [PMID: 24661570 DOI: 10.1111/joim.12239] [Cited by in Crossref: 108] [Cited by in F6Publishing: 88] [Article Influence: 15.4] [Reference Citation Analysis]
10 Karadagi A, Cavedon AG, Zemack H, Nowak G, Eybye ME, Zhu X, Guadagnin E, White RA, Rice LM, Frassetto AL, Strom S, Jorns C, Martini PGV, Ellis E. Systemic modified messenger RNA for replacement therapy in alpha 1-antitrypsin deficiency. Sci Rep 2020;10:7052. [PMID: 32341402 DOI: 10.1038/s41598-020-64017-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
11 Karadagi A, Johansson H, Zemack H, Salipalli S, Mörk LM, Kannisto K, Jorns C, Gramignoli R, Strom S, Stokkeland K, Ericzon BG, Jonigk D, Janciauskiene S, Nowak G, Ellis ECS. Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression. PLoS One 2017;12:e0177279. [PMID: 28486562 DOI: 10.1371/journal.pone.0177279] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
12 Hidvegi T, Stolz DB, Alcorn JF, Yousem SA, Wang J, Leme AS, Houghton AM, Hale P, Ewing M, Cai H, Garchar EA, Pastore N, Annunziata P, Kaminski N, Pilewski J, Shapiro SD, Pak SC, Silverman GA, Brunetti-Pierri N, Perlmutter DH. Enhancing Autophagy with Drugs or Lung-directed Gene Therapy Reverses the Pathological Effects of Respiratory Epithelial Cell Proteinopathy. J Biol Chem 2015;290:29742-57. [PMID: 26494620 DOI: 10.1074/jbc.M115.691253] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
13 Sabbagh DK, Barmayehvar B, Nguyen T, Edgar RG, Turner AM. Managing panniculitis in alpha-1 antitrypsin deficiency: Systematic review of evidence behind treatment. WJD 2018;7:1-8. [DOI: 10.5314/wjd.v7.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
14 Oishi K, Arnon R, Wasserstein MP, Diaz GA. Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management. Pediatr Transplant 2016;20:756-69. [PMID: 27329540 DOI: 10.1111/petr.12741] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
15 Guillaud O, Dumortier J, Traclet J, Restier L, Joly P, Chapuis-Cellier C, Lachaux A, Mornex JF. Assessment of liver fibrosis by transient elastography (Fibroscan®) in patients with A1AT deficiency. Clin Res Hepatol Gastroenterol 2019;43:77-81. [PMID: 30612958 DOI: 10.1016/j.clinre.2018.08.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
16 Campos-Murguía A, Valdéz-Hernández P, Cordova-Gallardo J, Arteaga-Vázquez J, Contreras AG, Vilatobá M, Cruz-Martínez R, Martínez-Benítez B, Gamboa-Domínguez A, Marfil-Garza BA, Flores-García NC, Márquez-Guillén E, García-Juárez I. Prevalence and clinical characteristics of alpha-1 antitrypsin deficiency in liver explants in a Mexican cohort. Clin Res Hepatol Gastroenterol 2021;45:101519. [PMID: 33636655 DOI: 10.1016/j.clinre.2020.07.024] [Reference Citation Analysis]
17 Menon J, Vij M, Sachan D, Rammohan A, Shanmugam N, Kaliamoorthy I, Rela M. Pediatric metabolic liver diseases: Evolving role of liver transplantation. World J Transplant 2021;11:161-79. [PMID: 34164292 DOI: 10.5500/wjt.v11.i6.161] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Strnad P, Schneider CV, Clark V. Clinical approach to liver disease in adults with AATD. In: Strnad P, Brantly ML, Bals R, editors. α 1 -Antitrypsin Deficiency. Sheffield: European Respiratory Society; 2019. pp. 114-26. [DOI: 10.1183/2312508x.10033018] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Raevens S, Boret M, De Pauw M, Fallon MB, Van Vlierberghe H. Pulmonary Abnormalities in Liver Disease: Relevance to Transplantation and Outcome. Hepatology 2021. [PMID: 33636019 DOI: 10.1002/hep.31770] [Reference Citation Analysis]
20 Townsend S, Newsome P, Turner AM. Presentation and prognosis of liver disease in alpha-1 antitrypsin deficiency. Expert Rev Gastroenterol Hepatol 2018;12:745-7. [PMID: 29768056 DOI: 10.1080/17474124.2018.1477589] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Hadzic N. Therapeutic Options in Alpha-1 Antitrypsin Deficiency: Liver Transplantation. In: Borel F, Mueller C, editors. Alpha-1 Antitrypsin Deficiency. New York: Springer; 2017. pp. 263-5. [DOI: 10.1007/978-1-4939-7163-3_26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Kubitz R, Dröge C, Kluge S, Stindt J, Stross C, Häussinger D, Flechtenmacher C, Wenning D, Teufel U, Schmitt CP, Engelmann G. High affinity anti-BSEP antibodies after liver transplantation for PFIC-2 - Successful treatment with immunoadsorption and B-cell depletion. Pediatr Transplantation 2016;20:987-93. [DOI: 10.1111/petr.12751] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Hadžić N, Baumann U, Mckiernan P, Mclin V, Nobili V. Long-term challenges and perspectives of pre-adolescent liver disease. The Lancet Gastroenterology & Hepatology 2017;2:435-45. [DOI: 10.1016/s2468-1253(16)30160-1] [Cited by in Crossref: 8] [Article Influence: 2.0] [Reference Citation Analysis]
24 Clark VC. Liver Transplantation in Alpha-1 Antitrypsin Deficiency. Clin Liver Dis 2017;21:355-65. [PMID: 28364818 DOI: 10.1016/j.cld.2016.12.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
25 Goldberg DS, Fallon MB. The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease. Clin Gastroenterol Hepatol 2015;13:2118-27. [PMID: 25934564 DOI: 10.1016/j.cgh.2015.04.024] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]